These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 1868675)

  • 1. Multiple-dose pharmacokinetics of ganglioside GM1 after intravenous and intramuscular administration to healthy volunteers.
    Rost KL; Brockmöller J; Weber W; Roots I
    Clin Pharmacol Ther; 1991 Aug; 50(2):141-9. PubMed ID: 1868675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of GM1 ganglioside following parenteral administration.
    Cornelli U; Panucci A; Zingali G; Kirschner G; Baggio C; Cogo R
    J Pharm Pharmacol; 1990 Oct; 42(10):708-11. PubMed ID: 1982143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parenteral administration of GM1 ganglioside to presenile Alzheimer patients.
    Svennerholm L; Gottfries CG; Blennow K; Fredman P; Karlsson I; Månsson JE; Toffano G; Wallin A
    Acta Neurol Scand; 1990 Jan; 81(1):48-53. PubMed ID: 2330815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disposition of exogenous tritium-labelled GM1lactone in the rat.
    Bellato P; Milan F; Facchinetti E; Toffano G
    Neurochem Int; 1992 Apr; 20(3):359-64. PubMed ID: 1304330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin 3-dependent mouse mast cells express the cholera toxin-binding acidic glycosphingolipid, ganglioside GM1, and increase their histamine content in response to toxin.
    Katz HR; Levine JS; Austen KF
    J Immunol; 1987 Sep; 139(5):1640-6. PubMed ID: 2957431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trial of ganglioside GM1 in acute stroke.
    Hoffbrand BI; Bingley PJ; Oppenheimer SM; Sheldon CD
    J Neurol Neurosurg Psychiatry; 1988 Sep; 51(9):1213-4. PubMed ID: 3066849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholera toxin B subunit-binding and ganglioside GM1 immuno-expression are not necessarily correlated in human salivary glands.
    Kirkeby S
    Acta Odontol Scand; 2014 Nov; 72(8):694-700. PubMed ID: 24655314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Competitive binding assay for quantitative determination of GM1 ganglioside in plasma and cerebrospinal fluid.
    Kirschner G; Bassan M; Facco MP; Ferrari G; Callegaro L
    J Pharm Biomed Anal; 1992; 10(2-3):163-6. PubMed ID: 1391096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The metabolism of radiolabelled GM1-ganglioside in cultured skin fibroblasts from controls and patients with GM1-gangliosidosis].
    Inui K
    Nihon Rinsho; 1995 Dec; 53(12):3102-4. PubMed ID: 8577066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lateral diffusion of ganglioside GM1 in phospholipid bilayer membranes.
    Goins B; Masserini M; Barisas BG; Freire E
    Biophys J; 1986 Apr; 49(4):849-56. PubMed ID: 3755064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the binding of cholera toxin to ganglioside GM1 immobilized onto microtitre plates.
    Dawson RM
    J Appl Toxicol; 2005; 25(1):30-8. PubMed ID: 15669043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo biodistribution of prion- and GM1-targeted polymersomes following intravenous administration in mice.
    Stojanov K; Georgieva JV; Brinkhuis RP; van Hest JC; Rutjes FP; Dierckx RA; de Vries EF; Zuhorn IS
    Mol Pharm; 2012 Jun; 9(6):1620-7. PubMed ID: 22536790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclic AMP-independent effects of cholera toxin on B cell activation. II. Binding of ganglioside GM1 induces B cell activation.
    Francis ML; Ryan J; Jobling MG; Holmes RK; Moss J; Mond JJ
    J Immunol; 1992 Apr; 148(7):1999-2005. PubMed ID: 1312102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cautionary note on the use of the B subunit of cholera toxin as a ganglioside GM1 probe: detection of cholera toxin A subunit in B subunit preparations by a sensitive adenylate cyclase assay.
    Spiegel S
    J Cell Biochem; 1990 Mar; 42(3):143-52. PubMed ID: 2156874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocytosis of cholera toxin in GERL-like structures of murine neuroblastoma cells pretreated with GM1 ganglioside. Cholera toxin internalization into Neuroblastoma GERL.
    Joseph KC; Stieber A; Gonatas NK
    J Cell Biol; 1979 Jun; 81(3):543-54. PubMed ID: 457774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of cholera toxin and membrane GM1 ganglioside of small intestine.
    Holmgren J; Lönnroth I; Månsson J; Svennerholm L
    Proc Natl Acad Sci U S A; 1975 Jul; 72(7):2520-4. PubMed ID: 1058471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding of cholera toxin B subunit: a surface marker for murine microglia but not oligodendrocytes or astrocytes.
    Nedelkoska L; Benjamins JA
    J Neurosci Res; 1998 Sep; 53(5):605-12. PubMed ID: 9726431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ganglioside GM1 in acute ischemic stroke. The SASS Trial.
    Stroke; 1994 Jun; 25(6):1141-8. PubMed ID: 8202971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Occurrence of glycosylation and deglycosylation of exogenously administered ganglioside GM1 in mouse liver.
    Ghidoni R; Sonnino S; Chigorno V; Venerando B; Tettamanti G
    Biochem J; 1983 Aug; 213(2):321-9. PubMed ID: 6615438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurite outgrowth is enhanced by anti-idiotypic monoclonal antibodies to the ganglioside GM1.
    Riggott MJ; Matthew WD
    Exp Neurol; 1997 May; 145(1):278-87. PubMed ID: 9184130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.